FMC Secures £4m Growth Capital from Coniston Backed Consortium

Deal News | Apr 09, 2025 | Coniston Capital

FMC, a portfolio company under the stewardship of private equity firm Coniston Capital, has successfully secured a £4 million growth capital investment. This capital raise was made possible with the participation of a consortium led by Barry Lanesman, a seasoned professional in the dental industry renowned for his instrumental role in the Dentex group's dramatic growth and subsequent merger with the Portman Group. This injection of funds is anticipated to provide FMC with the necessary liquidity and resources to facilitate its forthcoming expansion endeavors.

Sectors

Private Equity
Healthcare

Geography

United Kingdom – The capital raise for FMC and Barry Lanesman's background with the Dentex group primarily operating in the UK reflects the geographic focus of this investment and expansion activity.

Industry

Private Equity – Coniston Capital, a private equity firm, is actively involved in providing growth capital to FMC, facilitating its expansion strategy. This is typical of private equity investments aimed at scaling mid-sized businesses.
Healthcare – The involvement of Barry Lanesman, a dental industry leader, and the historical context of the Dentex group's growth highlight the focus on healthcare, specifically dental practice management and expansion.

Financials

£4m – The sum raised in the growth capital round by FMC from a consortium including Coniston Capital and Barry Lanesman.

Participants

Name	Role	Type	Description
FMC	Portfolio Company	Company	A company in which Coniston Capital has invested, receiving £4m for growth capital to fuel expansion.
Coniston Capital	Private Equity Firm	Company	The private equity firm backing FMC, leading the £4m growth capital round.
Barry Lanesman	Consortium Leader/Investor	Person	A notable figure in the dental industry, known for his leadership at Dentex group, contributing to the consortium providing the growth capital.